Go back

Funding floodgates open for clinical trials partnership

The European and Developing Countries Clinical Trials Partnership has received the green light for its 2017 work plan. This unlocks clinical trials funding worth €156.5 million (US$178.8m), much of which will target Africa.

The European Commission approved EDCTP’s plan on 3 July. Five calls for proposals were issued on the same day: €30m for innovations for poverty-related diseases, €34m for large-scale clinical trials, €38m for clinical trials which target pregnant women and children, €19m for neglected infectious diseases clinical trials, and €11m for neglected infectious disease product research.

An €800,000 fellowship scheme opens for applications on 14 July in partnership with the Africa Research Excellence Fund. This programme will allow postdoctoral researchers from Africa to be hosted by a university in an EU partner country.

Two calls will open in August: €2.5m for building ethics and regulatory capacity in sub-Saharan Africa, and €2.5m for career-development fellowships for junior and mid-career clinical researchers.

Three final calls will be issued in October and November: a €3m fellowship programme placing developing country researchers in European pharmaceutical companies for training, a €3m partnership with drug company GlaxoSmithKline in comorbidities between poverty-related diseases and noncommunicable diseases, and the EDCTP senior fellowships, worth up to €500,000 each.

For more details on the calls follow the links to the right of this article.